Tetanus Clinical Trials

245 clinical trials for Tetanus across international registries, including 8 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Phase 4 Study to Evaluate the Effectiveness and Safety of Siltartoxatug Injection for Tetanus Prophylaxis Following Injury — RECRUITING
• Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Anti-Tetanus Toxin Monoclonal Antibody Injection — RECRUITING · PHASE1
• Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective — RECRUITING
• A Registry： Siltartoxatug Injection for Tetanus Prophylaxis Following Injury — RECRUITING
• A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series — RECRUITING · PHASE2
• A Phase III Clinical Trail to Evaluate the Efficacy, Safety, Pharmacokinetics and Immunogenicity Characteristics of GR2001 Injection — RECRUITING · PHASE3
• Safety and Immunogenicity of DTaP-IPV/Hib Pentavalent Vaccine in Chinese 2-month-old Infants — RECRUITING · NA
• Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine — RECRUITING · PHASE1
• Phase I Clinical Trial of Adsorbed Tetanus Vaccine — ACTIVE_NOT_RECRUITING · PHASE1
• A Clinical Trial of Adsorbed Cell-free DPT Vaccine (5-component) (for People Aged 6 Years and Above) — COMPLETED · PHASE1
• A Clinical Trials of Adsorbed Cell-free DPT Vaccine (Five-component) — COMPLETED · PHASE2
• A Clinical Trial to Evaluate the Safety and Immunogenicity of a Single Dose of Adsorbed Tetanus Vaccine in a Population Aged 18 Years and Over — COMPLETED · PHASE3
• A Clinical Study on Immunogenicity Persistence of Adsorbed 5-component Acellular Pertussis, Diphtheria and Tetanus Combined Vaccine — NOT_YET_RECRUITING
• Phase I/III Clinical Trial of Adsorbed Tetanus Vaccine — COMPLETED · PHASE3
• A Study of Tetanus Antibody of Healthy Adults — COMPLETED
• A Phase Ⅲ Clinical Study of SNA02-48 Injection — NOT_YET_RECRUITING · PHASE3
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SNA02-48 Injection in Chinese Adult Participants — COMPLETED · PHASE1
• A First in Human Study Investigating the Safety of an Unloaded and Loaded (With a Tetanus-containing Vaccine Booster) Microneedle Patch in Healthy Adults — NOT_YET_RECRUITING · PHASE4
• Maternal Immunization With Tetanus Toxoid, Reduced Diphtheria Toxoid, Reduced-dose (2 µg) Recombinant Pertussis Vaccine (TdaP2gen) and Its Effect on the Immune Response in Thai Infants up to 15-18 Months Old — NOT_YET_RECRUITING · PHASE4
• A Phase I Clinical Trial of Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (For Adults and Adolescents) — NOT_YET_RECRUITING · PHASE1
• Safety Monitoring of Boostagen® Vaccine in Thailand — COMPLETED
• TETANUS Antibody Detection in Saliva Study — NOT_YET_RECRUITING · NA
• Phase I/II Clinical Trial of Diphtheria-Tetanus-Pertussis (Reduced Dose) Vaccine — NOT_YET_RECRUITING · PHASE1
• Confirmatory Study of BK1310 in Healthy Infants — COMPLETED · PHASE3
• Study of BK1301 (DTaP Vaccine) as a Booster in Adolescents — COMPLETED · PHASE3
• PFAS Exposure and Immune Response to Vaccination in Adults — COMPLETED · PHASE4
• Study to Compare the Anti-tetanus Neutralizing Antibody Titers and Safety of TNM002 Injection With Human Tetanus Immunoglobulin or Placebo in Adult Volunteers — COMPLETED · PHASE2
• A Phase 3 Study of BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed — ACTIVE_NOT_RECRUITING · PHASE3
• Study on the Safety and Immunogenicity of Boostrix Vaccine in Pregnant Malian Women and Their Infants — COMPLETED · PHASE2
• A Study to Evaluate the Safety and Immunogenicity of a Single Dose of Adsorbed Tetanus Vaccine in a Population Aged 18 Years and Over — COMPLETED · PHASE1
• Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of Age — NOT_YET_RECRUITING · PHASE2
• A Randomized, Open-Label, Parallel-Design Pharmacokinetic and Pharmacodynamic Interaction Study of TNM002 and Adsorbed Tetanus Vaccine — COMPLETED · PHASE1
• Safety and Immunogenicity of Tetanus Vaccine, Adsorbed in 18~44 Years Old Population — COMPLETED · PHASE3
• Real-time Artificial Intelligent (AI)-Assisted Muscle Ultrasound for Monitoring Muscle Mass Reduction in ICU Patients — COMPLETED · NA
• Study to Compare the Efficacy and Safety of Passive Immunization With TNM002 Injection and Human Tetanus Immunoglobulin as Prophylaxis Against Tetanus — COMPLETED · PHASE3
• Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of GR2001 in Chinese Healthy Adults — COMPLETED · PHASE1
• Impact of Boostrix™ Maternal Vaccination on Morbidity and Mortality of Pertussis Disease in Infants ≤6 Weeks of Age, in Bogota, Colombia. — COMPLETED
• Immunogenicity and Safety of Vaccine Against Tetanus and Diphtheria. — OTHER · PHASE3
• A Study to Evaluate Safety and Immunogenicity of APV006 in Healthy Adults — OTHER · PHASE1
• Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruS — COMPLETED · PHASE3
• Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary Series — OTHER · PHASE2
• Post-marketing Surveillance to Assess the Safety of Infanrix-IPV Vaccine Among Infants and Children in Korea — COMPLETED
• Tdap Vaccine Safety for Plasma Donors — COMPLETED · PHASE2
• Phase I Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed . — COMPLETED · PHASE1
• Randomized Controlled Trial of the Impact of Mobile Phone Delivered Reminders and Travel Subsidies to Improve Childhood Immunization Coverage Rates and Timeliness in Western Kenya — COMPLETED · NA
• A PHASE 1 RANDOMIZED, CONTROLLED, OBSERVER-BLINDED, MULTICENTER STUDY TO EVALUATE SAFETY, TOLERABILITY AND IMMUNOGENICITY OF AN INVESTIGATIONAL ADJUVANTED TETANUS/DIPHTHERIA/PERTUSSIS BOOSTER VACCINE (TDAP-1018) IN ACELLULAR PERTUSSIS VACCINE PRIMED HEALTHY VOLUNTEERS 18 TO 23 YEARS OF AGE — NOT_YET_RECRUITING · PHASE1
• Safety and Immunogenicity in Adults of Revaccination With Adacel® Vaccine 10 Years After a Previous Dose — COMPLETED · PHASE4
• Post Marketing Surveillance for ADACEL™ in South Korea — COMPLETED · PHASE4
• DTaP-IPV/Hib Vaccine Primary & Booster Vaccinations Versus Co-administration of DTaP-IPV and Hib Vaccine in Japanese Infants — COMPLETED · PHASE3
• Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease — COMPLETED

Refine this search